Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis

Código QR

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis

María J Moro-Álvarez1, Manuel Díaz-Curiel21Hospital Central Cruz Roja, Madrid, 2Fundación Jiménez Díaz, Madrid, Spain, Internal Medicine, Metabolic Bone Disease UnitAbstract: Postmenopausal osteoporosis increases susceptibility to low...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	María J Moro-Álvarez, Manuel Díaz-Curiel
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/2c92af5d20584aba942b4444933a767c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
por: Raja Bobba, et al.
Publicado: (2007)

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
por: Irene Lambrinoudaki, et al.
Publicado: (2008)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Philip Sambrook
Publicado: (2007)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Oliver Bock, et al.
Publicado: (2008)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
por: John Sunyecz
Publicado: (2008)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Tahir Masud, et al.
Publicado: (2009)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
por: Esteban Jódar-Gimeno
Publicado: (2007)

Effectiveness of the Mediterranean diet in the elderly
por: Blanca Roman, et al.
Publicado: (2008)

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
por: Peker N, et al.
Publicado: (2018)

Effect of 6 months of whole body vibration on lumbar spine bone density in postmenopausal women: a randomized controlled trial [Corrigendum]
por: Lai CL, et al.
Publicado: (2014)

Teriparatide in the management of osteoporosis
por: Donald Bodenner, et al.
Publicado: (2008)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate H, et al.
Publicado: (2011)

Osteoporosis screening and risk management
por: Consuelo H Wilkins
Publicado: (2007)

Clinical challenges in the management of osteoporosis
por: Sheryl F Vondracek, et al.
Publicado: (2008)

Osteoporosis in the aging male: Treatment options
por: Stephen P Tuck, et al.
Publicado: (2008)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Hisaya Kawate, et al.
Publicado: (2010)

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
por: Baccaro LF, et al.
Publicado: (2015)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle OA, et al.
Publicado: (2018)

The effect of a combined oral calcium and vitamin D supplement for treating mild to moderate vitamin D deficiency in postmenopausal women
por: Terry Golombick, et al.
Publicado: (2008)

The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
por: Silvia Migliaccio, et al.
Publicado: (2007)

Rehabilitating a brain with Alzheimer's: a proposal
por: Gonzalo Emiliano Aranda-Abreu, et al.
Publicado: (2011)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu H, et al.
Publicado: (2019)

Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study
por: Fan Z, et al.
Publicado: (2020)

BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women
por: Ma Z, et al.
Publicado: (2016)

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
por: Liu Z, et al.
Publicado: (2020)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara S, et al.
Publicado: (2014)

Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
por: Fan T, et al.
Publicado: (2013)

Nurse home visits with or without alert buttons versus usual care in the frail elderly: a randomized controlled trial
por: Favela J, et al.
Publicado: (2013)

Diagnosis of Presarcopenia Using Body Height and Arm Span for Postmenopausal Osteoporosis
por: Ono Y, et al.
Publicado: (2020)

Effect of 6-month community-based exercise interventions on gait and functional fitness of an older population: a quasi-experimental study
por: Ramalho F, et al.
Publicado: (2018)

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Luigi Gennari, et al.
Publicado: (2010)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Piet Geusens
Publicado: (2009)

Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures
por: Ciubean AD, et al.
Publicado: (2018)

Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas KM, et al.
Publicado: (2014)

Pharmacological treatment of osteoporosis in the oldest old
por: Vandenbroucke A, et al.
Publicado: (2017)

Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty
por: Tao Y, et al.
Publicado: (2021)

Potential underdiagnosis of osteoporosis in repeated vertebral augmentation for new vertebral compression fractures
por: İlhan B, et al.
Publicado: (2015)

Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update
por: Nagy EE, et al.
Publicado: (2020)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011)